DRN-10557-72759
2 vaccinations
8 coded responses
11 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 366 / AL
- Registered
- 2021-04-29
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-04-29
Registered in v-safe
-
2021-04-29
Dose 1 — Pfizer-BioNTech
-
2021-04-29
Survey response — day 0, dose 1MedDRA: Injection site warmth — Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesFree text: Heat in injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Survey response — days 1–6 daily, dose 1MedDRA: Injection site warmth — Feeling: Good · Site: Pain, Swelling · Joint painsFree text: heat located around the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Survey response — day 14, dose 1MedDRA: Fatigue, Pre-existing disease, Seizure — Feeling: Fair · Be unable to do your normal daily activitiesFree text: More tiredness and being having more unusual seizures in my sleepMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Dose 2 — Pfizer-BioNTech
-
2021-05-30
Survey response — day 7, dose 2MedDRA: Pain in extremity — Feeling: Fair · Site: Pain · Joint pains · Be unable to do your normal daily activitiesFree text: Whole arm the shot was given in has pain and goes with pain for several hour.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-03
- 2021-06-10
-
2021-06-26
Survey response — day 35, dose 2MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Why tell you the sysmptoms when it is clear that the CDC never cared and the FDA never cared about another medication given with side effects when reported.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-01
-
2021-08-19
Survey response — 3 months, dose 2MedDRA: Condition aggravated, Hypoaesthesia, Insomnia, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Difficult sleeping, more sub seizures at higher numbers, more lose of feels or numb feeling in armsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-20
Survey response — 6 months, dose 2MedDRA: Amnesia, Weight increased — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Weight gain, loss of memoryMedDRA releases: 2024-11 · check-in free text available
-
2021-11-20
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-29
-
2022-05-20
Survey response — 12 months, dose 2MedDRA: Depression, Weight increased — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Weight gain and depressionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-29 | Pfizer-BioNTech | |
| 2 | 2021-05-20 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 0, dose 1
Systemic reaction (other): Heat in injection site
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): heat located around the injection site
Release 8 — day 14, dose 1
Symptoms: More tiredness and being having more unusual seizures in my sleep
Release 8 — day 7, dose 2
Systemic reaction (other): Whole arm the shot was given in has pain and goes with pain for several hour.
Release 9 — day 35, dose 2
Symptoms: Why tell you the sysmptoms when it is clear that the CDC never cared and the FDA never cared about another medication given with side effects when reported.
Release 9 — 3 months, dose 2
Symptoms: Difficult sleeping, more sub seizures at higher numbers, more lose of feels or numb feeling in arms
Release 10 — 6 months, dose 2
Symptoms: Weight gain, loss of memory
Release 11 — 12 months, dose 2
Symptoms: Weight gain and depression
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Amnesia | · | · | ✓ |
| SD | Condition aggravated | ✓ | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | ✓ | · | ✓ |
| SD | Insomnia | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Seizure | ✓ | ✓ | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Weight increased | · | · | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release